Skip to main content

Mother/Infant Opioid Substance Use Treatment and Recovery Effort (MOSTaRE)

Interested in Getting Involved?

Need More Info?
Contact:
ella.rusnacko@minnesotaperinatal.org

The MOSTaRE initiative has concluded, but we are excited to announce that our new Linking Identification & Navigation for Perinatal Mental Health & Substance Use Care (LINK) Initiative is now open for statewide enrollment to Minnesota hospital teams. This initiative focuses on addressing the complex challenges faced by pregnant and postpartum individuals dealing with mental health conditions and substance use disorders. Through the integration of evidence-based AIM bundles, LINK aims to enhance maternal and neonatal outcomes by increasing identification and referrals for mental health and substance use care.

Monthly calls for LINK are scheduled on the following dates from 12pm to 1pm:
  • December 12th, 2024
  • January 9th, 2025
  • February 13th, 2025
  • March 13th, 2025
  • April 10th, 2025
  • May 8th, 2025
  • June 12th, 2025
  • July 10th, 2025
  • August 14th, 2025
  • September 11th, 2025
  • October 9th, 2025
This ongoing initiative allows hospital teams to engage in collaborative learning, receive quality improvement support, and contribute to advancing equitable care practices statewide.

Hospital teams are welcome to join anytime; for more information or to register your facility, please contact Ella Krispin at ella.rusnacko@minnesotaperinatal.org.

MOSTaRE Cohort 1

These are a variety of resources provided by MPO/MNPQC and other organizations for healthcare providers and the public. Many links are provided by other organizations and are subject to change without notice.


LINK Initiative

AIM

By December 2023, our aim is to increase the identification and treatment of substance use disorders (SUDs) in pregnant people and substance exposure in infants by 50% or more in order to improve pregnancy and postpartum outcomes, increase the use of non-pharmacologic methods for treating infants exposed to opioids and reduce the average length of stay for these infants.

Charter

The Mother/Infant Opioid and Substance use Treatment and Recovery Effort (MOSTaRE) purpose is to work with providers, hospitals, and other stakeholders to improve identification, clinical care, and coordinated treatment/support for pregnant and parenting individuals with opioid use disorder and their infants through a family-centered care approach. 

The MOSTaRE Initiative will emphasize family-centered care that maintains the dyad and will address treatment and prevention of substance exposure during and after pregnancy for both mother and infant.

Team Membership (includes both infant/perinatal arms)

  1. Infant Team Members include:  NICU, general pediatric or family practice provider, community treatment and support partners, women with lived experience 
  2. Perinatal Team Members include:  prenatal, delivery, and postpartum providers; treatment and community support members, women with lived experience 

MOSTaRE Charter

Family Of Measures

Stratify by race/ethnicity where available.

State Surveillance:

  • SUD among pregnant and postpartum people (SS1)
  • Severe Maternal Morbidity (SMM) (including transfusion codes) among people with SUD (SS2)
  • Severe Maternal Morbidity (SMM) (excluding transfusion codes) among people with SUD (SS3)
  • Proportion of pregnancy associated deaths due to overdose (SS4)

Outcome Measures

  • Percent of newborns exposed to substances in utero who were discharged to either birth parent (O1)
  • Percent of pregnancy and postpartum people who received or were referred to recovery treatment services (O3)
  • Length of stay of all opioid exposed newborns

Process Measures:

  • Percent of pregnant and postpartum people screened for SUDs (P1)
  • Number of Provider and Nursing education-SUDs (P5)
  • Number of Provider and Nursing education- Respectful and Equitable Care (P6)

Structure Measures:

  • Resource Mapping/ Identification of Community Resources (S1)
  • Number of Patient Event Debriefs (S2)
  • General Pain Managment Guidelines (S3) 
  • OUD Pain Managment Guidelines (S4) 
  • Validated Screening Tools and Resources Shared with Prenatal Care Sites (S5)

Resources


Faculty

Working Group


Interested in Getting Involved?
Need More Info?